cagrilintide and tirzepatide together with CagriTirz (Cagrilintide + Tirzepatide) 10mg(5mg+5mg) Cagrilintide, Tirzepatide, and Retatrutide Peptides:

Microdosing tirzepatide is another approach where smaller, more frequent doses are used

| | Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity

Common side effects reported with retatrutide include: Nausea, vomiting, and diarrhoea (most frequent, particularly during dose escalation) Decreased appetite Constipation Injection site reactions Mild increases in heart rate Cagrilintide has demonstrated a generally well-tolerated profile, with gastrointestinal symptoms also being the most commonly reported adverse effects

Loss of coordination and clumsiness in handling objects

Oily skin types benefit from lightweight, non-comedogenic copper peptide serums and pairing with oil-free hydrators